Search





Search





Markets
/
Stocks
/
nasdaq-syk
/

Stryker Corp

SYK

Add to Watchlist

302.105USD

+7.655+2.60%

Close 05/13, 16:00（ET）Quotes delayed by 15 min

115.83BMarket Cap

34.62P/E TTM



Stryker Corp

302.105

+7.655+2.60%

Overview Financials Discussions Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Stryker Corp

Currency: USD Updated: 2026-05-12

Key Insights

Stryker Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 392.55.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stryker Corp's Score

Industry at a Glance

Industry Ranking

12 / 206

Overall Ranking

85 / 4490

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Stryker Corp Highlights

StrengthsRisks

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 22.53% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 41.30%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 41.30%.

Undervalued

The company’s latest PE is 33.75, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 312.34M shares, decreasing 1.14% quarter-over-quarter.

Held by Brandes Investmen

Star Investor Brandes Investmen holds 477.00 shares of this stock.

Analyst Rating

Based on 32 analysts

Buy

Current Rating

392.550

Target Price

+37.51%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-12

The current financial score of Stryker Corp is 9.37, ranking 3 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 6.02B, representing a year-over-year increase of 2.63%, while its net profit experienced a year-over-year increase of 13.91%.

Score

Industry at a Glance

Previous score

9.37

Change



Financials

8.15

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.66

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.25

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.77

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Stryker Corp's Company Valuation

Currency: USD Updated: 2026-05-12

The current valuation score of Stryker Corp is 6.29, ranking 163 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 33.75, which is 56.41% below the recent high of 52.78 and 4.03% above the recent low of 32.39.

Score

Industry at a Glance

Previous score

6.29

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 12/206

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-12

The current earnings forecast score of Stryker Corp is 8.19, ranking 57 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 435.00, with a high of 465.00 and a low of 317.70.

Score

Industry at a Glance

Previous score

8.19

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 32 analysts

Buy

Current Rating

392.550

Target Price

+38.92%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

116

Total

Median

Average

Company name

Ratings

Analysts

Stryker Corp

SYK

Medtronic PLC

MDT

Dexcom Inc

DXCM

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Insulet Corp

PODD

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-12

The current price momentum score of Stryker Corp is 6.96, ranking 86 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 334.81 and the support level at 267.54, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.64

Change

0.32

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-1.666

Sell

RSI(14)

41.615

Neutral

STOCH(KDJ)(9,3,3)

42.832

Buy

ATR(14)

9.563

Low Volatility

CCI(14)

-25.031

Neutral

Williams %R

60.646

Sell

TRIX(12,20)

-0.629

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

291.764

Buy

MA10

294.714

Buy

MA20

312.328

Sell

MA50

330.186

Sell

MA100

347.119

Sell

MA200

360.461

Sell

Institutional Confidence

Currency: USD Updated: 2026-05-12

The current institutional shareholding score of Stryker Corp is 7.00, ranking 80 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 81.56%, representing a quarter-over-quarter decrease of 0.80%. The largest institutional shareholder is PRFDX, holding a total of 9.61M shares, representing 2.51% of shares outstanding, with 17.54% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Brown (John W)

20.06M

BlackRock Institutional Trust Company, N.A.

16.84M

+3.53%

Greenleaf Trust

15.31M

-7.55%

State Street Investment Management (US)

15.25M

+2.08%

T. Rowe Price Associates, Inc.

Star Investors

9.61M

-8.33%

JP Morgan Asset Management

8.00M

+12.17%

Geode Capital Management, L.L.C.

7.54M

+0.94%

Wellington Management Company, LLP

6.49M

+22.64%

Risk Assessment

Currency: USD Updated: 2026-05-12

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Stryker Corp is 9.56, ranking 5 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.79. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.